{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:20:38Z","timestamp":1787804438415,"version":"build-2784847793"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018556","name":"Science and Technology Program of Suzhou","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018556","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012462","name":"Collaborative Innovation Center of Suzhou Nano Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012462","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jconrel.2026.115122","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T23:35:29Z","timestamp":1782171329000},"page":"115122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Engineered bacterial membrane vesicles as transdermal cancer vaccines"],"prefix":"10.1016","volume":"397","author":[{"given":"Jiayi","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhuo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.115122_bb0005","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/ni1307","article-title":"Langerhans cells arise from monocytes in vivo","volume":"7","author":"Ginhoux","year":"2006","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2026.115122_bb0010","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1038\/s41590-021-01067-0","article-title":"Homeostatic IL-13 in healthy skin directs dendritic cell differentiation to promote TH2 and inhibit TH17 cell polarization","volume":"22","author":"Mayer","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2026.115122_bb0015","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.it.2017.06.008","article-title":"Langerhans cells \u2013 the macrophage in dendritic cell clothing","volume":"38","author":"Doebel","year":"2017","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jconrel.2026.115122_bb0020","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s41385-022-00505-y","article-title":"Skin immunity: dissecting the complex biology of our body\u2019s outer barrier","volume":"15","author":"Zhang","year":"2022","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.jconrel.2026.115122_bb0025","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41577-018-0084-5","article-title":"The immunological anatomy of the skin","volume":"19","author":"Kabashima","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.115122_bb0030","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202107960","article-title":"Nanocarriers for skin applications: where do we stand?","volume":"61","author":"Tiwari","year":"2022","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2026.115122_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120410","article-title":"Progress and perspective of microneedle system for anti-cancer drug delivery","volume":"264","author":"Li","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.115122_bb0040","article-title":"Bioinspired and biomimetic delivery platforms for cancer vaccines","volume":"34","author":"Liu","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115122_bb0045","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/s41551-020-00650-4","article-title":"Transdermal microneedles for the programmable burst release of multiple vaccine payloads","volume":"5","author":"Tran","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.115122_bb0050","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jconrel.2010.09.018","article-title":"Advances in transcutaneous vaccine delivery: do all ways lead to Rome?","volume":"148","author":"Bal","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115122_bb0055","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41573-023-00670-0","article-title":"Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems","volume":"22","author":"Baryakova","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115122_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114263","article-title":"Development of a dissolving microneedle patch for transdermal delivery of SARS-CoV-2 mRNA vaccine with enhanced stability and immunogenicity","volume":"388","author":"Tang","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115122_bb0065","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/s41590-025-02145-3","article-title":"Cutaneous T cell immunity","volume":"26","author":"Zareie","year":"2025","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2026.115122_bb0070","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41577-023-00853-1","article-title":"Assessing the generation of tissue resident memory T cells by vaccines","volume":"23","author":"Rotrosen","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.115122_bb0075","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/nm.3962","article-title":"Hair follicle-derived IL-7 and IL-15 mediate skin-resident memory T cell homeostasis and lymphoma","volume":"21","author":"Adachi","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2026.115122_bb0080","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nature10851","article-title":"Skin infection generates non-migratory memory CD8+ TRM cells providing global skin immunity","volume":"483","author":"Jiang","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115122_bb0085","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.4049\/jimmunol.1601367","article-title":"Cutting edge: tissue-resident memory T cells generated by multiple immunizations or localized deposition provide enhanced immunity","volume":"198","author":"Davies","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2026.115122_bb0090","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/S0140-6736(24)00532-4","article-title":"A measles and rubella vaccine microneedle patch in the Gambia: a phase 1\/2, double-blind, double-dummy, randomised, active-controlled, age de-escalation trial","volume":"403","author":"Adigweme","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2026.115122_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0303450","article-title":"Phase 1, randomized, rater and participant blinded placebo-controlled study of the safety, reactogenicity, tolerability and immunogenicity of H1N1 influenza vaccine delivered by VX-103 (a MIMIX microneedle patch [MAP] system) in healthy adults","volume":"19","author":"Garg","year":"2024","journal-title":"PloS One"},{"key":"10.1016\/j.jconrel.2026.115122_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003024","article-title":"Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: results from a randomized, controlled phase I clinical trial","volume":"17","author":"Forster","year":"2020","journal-title":"PLoS Med."},{"key":"10.1016\/j.jconrel.2026.115122_bb0105","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0140-6736(17)30575-5","article-title":"The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial","volume":"390","author":"Rouphael","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2026.115122_bb0110","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-025-09729-x","article-title":"A skin-permeable polymer for non-invasive transdermal insulin delivery","volume":"648","author":"Wei","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115122_bb0115","doi-asserted-by":"crossref","first-page":"5812","DOI":"10.1039\/D4TB00659C","article-title":"Dissolving microneedles for transdermal drug delivery in cancer immunotherapy","volume":"12","author":"Xiang","year":"2024","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2026.115122_bb0120","first-page":"115","article-title":"Transdermal delivery of PeptiCRAd cancer vaccine using microneedle patches","volume":"45","author":"D\u2019Amico","year":"2025","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2026.115122_bb0125","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41579-023-00875-5","article-title":"Composition and functions of bacterial membrane vesicles","volume":"21","author":"Toyofuku","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jconrel.2026.115122_bb0130","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.drudis.2020.12.017","article-title":"Biomimetic bacterial and viral-based nanovesicles for drug delivery, theranostics, and vaccine applications","volume":"26","author":"Loo","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2026.115122_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114340","article-title":"Engineering bacterial membrane nanovesicles for improved therapies in infectious diseases and cancer","volume":"186","author":"Gao","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115122_bb0140","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.biomaterials.2016.10.037","article-title":"Bacterial protoplast-derived nanovesicles for tumor targeted delivery of chemotherapeutics","volume":"113","author":"Kim","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.115122_bb0145","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1039\/D5CS00440C","article-title":"Biomimetic liposomes in drug delivery: from design mechanisms to applications","volume":"55","author":"Li","year":"2026","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2026.115122_bb0150","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40580-024-00434-5","article-title":"Bacteria extracellular vesicle as nanopharmaceuticals for versatile biomedical potential","volume":"11","author":"Ho","year":"2024","journal-title":"Nano Converg."},{"key":"10.1016\/j.jconrel.2026.115122_bb0155","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1021\/nl503508h","article-title":"Bacterial protoplast-derived nanovesicles as vaccine delivery system against bacterial infection","volume":"15","author":"Kim","year":"2015","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2026.115122_bb0160","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202506174","article-title":"Inhalable nanovaccine based on bioengineered bacteria-derived membrane vesicles against lung metastasis","volume":"38","author":"Miao","year":"2026","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115122_bb0165","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41378-024-00743-z","article-title":"Bacterial nanotechnology as a paradigm in targeted cancer therapeutic delivery and immunotherapy","volume":"10","author":"Gholami","year":"2024","journal-title":"Microsyst. Nanoeng."},{"key":"10.1016\/j.jconrel.2026.115122_bb0170","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jconrel.2022.09.025","article-title":"Overcoming skin barriers through advanced transdermal drug delivery approaches","volume":"351","author":"Phatale","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115122_bb0175","doi-asserted-by":"crossref","first-page":"9693","DOI":"10.1021\/acsnano.8b03800","article-title":"Enhanced transdermal drug delivery by transfersome-embedded oligopeptide hydrogel for topical chemotherapy of melanoma","volume":"12","author":"Jiang","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115122_bb0180","doi-asserted-by":"crossref","first-page":"8653","DOI":"10.1039\/C7TB02529G","article-title":"Nanomaterials for transdermal drug delivery: beyond the state of the art of liposomal structures","volume":"5","author":"Jijie","year":"2017","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2026.115122_bb0185","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.addr.2020.06.016","article-title":"Noninvasive transdermal delivery of liposomes by weak electric current","volume":"154\u2013155","author":"Hasan","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115122_bb0190","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jdermsci.2009.12.005","article-title":"Targeting to the hair follicles: current status and potential","volume":"57","author":"Wosicka","year":"2010","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jconrel.2026.115122_bb0195","article-title":"Non-invasive transdermal delivery of biomacromolecules with fluorocarbon-modified chitosan for melanoma immunotherapy and viral vaccines","volume":"15","author":"Zhu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115122_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.812774","article-title":"Toll-like receptor signaling and its role in cell-mediated immunity","volume":"13","author":"Duan","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115122_bb0205","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41551-021-00834-6","article-title":"Systemic immune responses to irradiated tumours via the transport of antigens to the tumour periphery by injected flagellate bacteria","volume":"6","author":"Wang","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.115122_bb0210","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-66622-x","article-title":"Probiotic-based oral vaccine mucosal delivery system enabling genetically encoded dual-antigen arrays","volume":"16","author":"Yue","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115122_bb0215","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/s41590-025-02376-4","article-title":"Targeting autocrine retinoic acid signaling by ALDH1A2 inhibition enhances antitumor dendritic cell vaccine efficacy","volume":"27","author":"Fang","year":"2026","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2026.115122_bb0220","article-title":"Lipid nanoparticle-mediated lymph node-targeting delivery of mRNA cancer vaccine elicits robust CD8+ T cell response","volume":"119","author":"Chen","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2026.115122_bb0225","article-title":"Bioengineered bacteria-derived outer membrane vesicles as a versatile antigen display platform for tumor vaccination via plug-and-display technology","volume":"12","author":"Cheng","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115122_bb0230","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1021\/acsnano.4c00654","article-title":"Tumor vaccine exploiting membranes with influenza virus-induced immunogenic cell death to decorate polylactic coglycolic acid nanoparticles","volume":"19","author":"Yang","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115122_bb0235","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.3390\/polym14081608","article-title":"Microneedles in action: microneedling and microneedles-assisted transdermal delivery","volume":"14","author":"Lim","year":"2022","journal-title":"Polymers"},{"key":"10.1016\/j.jconrel.2026.115122_bb0240","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/AJP.0b013e31816778f9","article-title":"Effect of microneedle design on pain in human volunteers","volume":"24","author":"Gill","year":"2008","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.jconrel.2026.115122_bb0245","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jconrel.2020.12.019","article-title":"Microneedles for painless transdermal immunotherapeutic applications","volume":"330","author":"Amani","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115122_bb0250","series-title":"Regulatory Considerations for Microneedling Products: Guidance for Industry and Food and Drug Administration Staff","author":"U.S. Food and Drug Administration","year":"2020"},{"key":"10.1016\/j.jconrel.2026.115122_bb0255","doi-asserted-by":"crossref","first-page":"8882","DOI":"10.3390\/ijms22168882","article-title":"Targeting cytokines, pathogen-associated molecular patterns, and damage-associated molecular patterns in sepsis via blood purification","volume":"22","author":"Moriyama","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115122_bb0260","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1089\/ars.2021.0005","article-title":"Targeting Toll-like receptors in sepsis: from bench to clinical trials","volume":"35","author":"Chen","year":"2021","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.jconrel.2026.115122_bb0265","doi-asserted-by":"crossref","first-page":"14233","DOI":"10.1038\/s41598-022-18204-w","article-title":"Application of an instructive hydrogel accelerates re-epithelialization of xenografted human skin wounds","volume":"12","author":"Sparks","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.115122_bb0270","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1089\/scd.2021.0124","article-title":"Histology scoring system for murine cutaneous wounds","volume":"30","author":"van de Vyver","year":"2021","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.jconrel.2026.115122_bb0275","doi-asserted-by":"crossref","first-page":"20057","DOI":"10.1021\/acsnano.2c07843","article-title":"Hyaluronic acid nanoparticles as a topical agent for treating psoriasis","volume":"16","author":"Lee","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115122_bb0280","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3390\/md16100378","article-title":"Fucoxanthin-containing cream prevents epidermal hyperplasia and UVB-induced skin erythema in mice","volume":"16","author":"Rodr\u00edguez-Luna","year":"2018","journal-title":"Mar. Drugs"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926005250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926005250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:16:19Z","timestamp":1787804179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926005250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":56,"alternative-id":["S0168365926005250"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115122","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineered bacterial membrane vesicles as transdermal cancer vaccines","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115122","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115122"}}